Treatment of infantile-onset Pompe disease in a rat model with muscle-directed AAV gene therapy

Treatment of infantile-onset Pompe disease in a rat model with muscle-directed AAV gene therapy

Objective: Pompe disease (PD) is caused by deficiency of the lysosomal enzyme acid α-glucosidase (GAA), leading to progressive glycogen accumulation and severe myopathy with progressive muscle weakness. In the Infantile-Onset PD (IOPD), death generally occurs <1 year of age. There is no cure for...

Full description

Bibliographic Details
Main Authors: Sergio Muñoz, Joan Bertolin, Veronica Jimenez, Maria Luisa Jaén, Miquel Garcia, Anna Pujol, Laia Vilà, Victor Sacristan, Elena Barbon, Giuseppe Ronzitti, Jihad El Andari, Warut Tulalamba, Quang Hong Pham, Jesus Ruberte, Thierry VandenDriessche, Marinee K. Chuah, Dirk Grimm, Federico Mingozzi, Fatima Bosch
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Molecular Metabolism
Subjects:
Glycogen metabolism
Myopathies
Pompe disease
Rat model
Gene therapy
AAV
Online Access:http://www.sciencedirect.com/science/article/pii/S2212877824000309

Internet

http://www.sciencedirect.com/science/article/pii/S2212877824000309

Similar Items